dr. heymach on the significance of nivolumab for lung cancer
Published 7 years ago • 481 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:01
dr. heymach on nivolumab for lung cancer
-
1:58
dr. heymach discusses the checkmate-026 study in lung cancer
-
1:32
dr. heymach on new kras subsets in lung cancer
-
0:52
dr. hellmann on the design of the checkmate-032 study for lung cancer
-
1:24
dr. ernstoff discusses nivolumab and ipilimumab in advanced melanoma
-
55:38
novel therapy for lung cancer: from targeted therapy to immuno-therapy and back again!
-
4:25
the phenomenon of immunotherapy in melanoma
-
7:48
hologic ceo steve macmillan on breast cancer detection, future of ai-powered diagnostics
-
2:13
nivolumab in hnscc
-
2:04
dr. patrick m. forde on neoadjuvant dr. patrick m. forde on neoadjuvant nivolumab in nsclc
-
4:41
final thoughts on immunotherapy
-
0:57
dr. postow on os results of checkmate-069 study
-
2:01
meet thoracic head and neck medical oncologist john heymach, m.d., ph.d.
-
1:01
dr. el-deiry on the significance of understanding tumor heterogeneity
-
4:49
in early-stage nsclc, give nivolumab before or after surgery?
-
1:49
the significance of the ipilimumab/nivolumab findings in melanoma
-
3:24
ipi/nivo in metastatic nsclc
-
2:08
dr. bunn on missed endpoint in checkmate-026 for nsclc
-
1:24
dr. higano on docetaxel for hormone-sensitive prostate cancer